These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22562960)

  • 1. Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation.
    Basaria S; Davda MN; Travison TG; Ulloor J; Singh R; Bhasin S
    J Gerontol A Biol Sci Med Sci; 2013 Feb; 68(2):153-60. PubMed ID: 22562960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation.
    Travison TG; Basaria S; Storer TW; Jette AM; Miciek R; Farwell WR; Choong K; Lakshman K; Mazer NA; Coviello AD; Knapp PE; Ulloor J; Zhang A; Brooks B; Nguyen AH; Eder R; LeBrasseur N; Elmi A; Appleman E; Hede-Brierley L; Bhasin G; Bhatia A; Lazzari A; Davis S; Ni P; Collins L; Bhasin S
    J Gerontol A Biol Sci Med Sci; 2011 Oct; 66(10):1090-9. PubMed ID: 21697501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Plasma Testosterone Is Associated With Elevated Cardiovascular Disease Biomarkers.
    Pastuszak AW; Kohn TP; Estis J; Lipshultz LI
    J Sex Med; 2017 Sep; 14(9):1095-1103. PubMed ID: 28757119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events associated with testosterone administration.
    Basaria S; Coviello AD; Travison TG; Storer TW; Farwell WR; Jette AM; Eder R; Tennstedt S; Ulloor J; Zhang A; Choong K; Lakshman KM; Mazer NA; Miciek R; Krasnoff J; Elmi A; Knapp PE; Brooks B; Appleman E; Aggarwal S; Bhasin G; Hede-Brierley L; Bhatia A; Collins L; LeBrasseur N; Fiore LD; Bhasin S
    N Engl J Med; 2010 Jul; 363(2):109-22. PubMed ID: 20592293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.
    Smith AM; English KM; Malkin CJ; Jones RD; Jones TH; Channer KS
    Eur J Endocrinol; 2005 Feb; 152(2):285-91. PubMed ID: 15745938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the Framingham Heart Study.
    Jasuja GK; Travison TG; Davda M; Murabito JM; Basaria S; Zhang A; Kushnir MM; Rockwood AL; Meikle W; Pencina MJ; Coviello A; Rose AJ; D'Agostino R; Vasan RS; Bhasin S
    J Gerontol A Biol Sci Med Sci; 2013 Jun; 68(6):733-40. PubMed ID: 23105044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial.
    Huang G; Bhasin S; Tang ER; Aakil A; Anderson SW; Jara H; Davda M; Travison TG; Basaria S
    J Gerontol A Biol Sci Med Sci; 2013 Aug; 68(8):954-9. PubMed ID: 23292288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone Attenuates Age-Related Fall in Aerobic Function in Mobility Limited Older Men With Low Testosterone.
    Storer TW; Bhasin S; Travison TG; Pencina K; Miciek R; McKinnon J; Basaria S
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2562-9. PubMed ID: 27050869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community.
    Joseph J; Pencina MJ; Wang TJ; Hayes L; Tofler GH; Jacques P; Selhub J; Levy D; D'Agostino RB; Benjamin EJ; Vasan RS
    J Hypertens; 2009 Jun; 27(6):1317-24. PubMed ID: 19357531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
    Boden WE; Miller MG; McBride R; Harvey C; Snabes MC; Schmidt J; McGovern ME; Fleg JL; Desvigne-Nickens P; Anderson T; Kashyap M; Probstfield JL
    Am Heart J; 2020 Jun; 224():65-76. PubMed ID: 32335402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials.
    Bhasin S; Ellenberg SS; Storer TW; Basaria S; Pahor M; Stephens-Shields AJ; Cauley JA; Ensrud KE; Farrar JT; Cella D; Matsumoto AM; Cunningham GR; Swerdloff RS; Wang C; Lewis CE; Molitch ME; Barrett-Connor E; Crandall JP; Hou X; Preston P; Cifelli D; Snyder PJ; Gill TM
    Lancet Diabetes Endocrinol; 2018 Nov; 6(11):879-890. PubMed ID: 30366567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study.
    Krasnoff JB; Basaria S; Pencina MJ; Jasuja GK; Vasan RS; Ulloor J; Zhang A; Coviello A; Kelly-Hayes M; D'Agostino RB; Wolf PA; Bhasin S; Murabito JM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2790-9. PubMed ID: 20382680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetes.
    Gianatti EJ; Hoermann R; Lam Q; Dupuis P; Zajac JD; Grossmann M
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):55-62. PubMed ID: 26120052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
    Leder BZ; Finkelstein JS
    Osteoporos Int; 2005 Dec; 16(12):1487-94. PubMed ID: 15856361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
    Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum testosterone and mortality in older men.
    Laughlin GA; Barrett-Connor E; Bergstrom J
    J Clin Endocrinol Metab; 2008 Jan; 93(1):68-75. PubMed ID: 17911176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Estrogen Levels and Self-Reported Health and Mobility Limitation in Community-Dwelling Men of the Framingham Heart Study.
    Jasuja GK; Travison TG; Murabito JM; Davda MN; Rose AJ; Basaria S; Coviello A; Vasan RS; D'Agostino R; Bhasin S
    J Gerontol A Biol Sci Med Sci; 2017 Aug; 72(8):1137-1142. PubMed ID: 28329787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
    Kenny AM; Prestwood KM; Gruman CA; Marcello KM; Raisz LG
    J Gerontol A Biol Sci Med Sci; 2001 May; 56(5):M266-72. PubMed ID: 11320105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body composition, not body weight, is related to cardiovascular disease risk factors and sex hormone levels in men.
    Segal KR; Dunaif A; Gutin B; Albu J; Nyman A; Pi-Sunyer FX
    J Clin Invest; 1987 Oct; 80(4):1050-5. PubMed ID: 3654969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.